MG

Michael Gutbrod

Senior Associate at SANTÉ

Cambridge, Massachusetts

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

CRISPR-mediated mutagenesis and screening
Next Generation Sequencing Library Preparation and Analysis
Molecular & Cellular Biology
Mammalian Cell Culture
Scientific Writing
CRISPR
Genetic Engineering
Western Blotting
Real-Time Polymerase Chain Reaction (qPCR)
Stem Cells
Stem Cell Differentiation
FACS
Fluorescence Microscopy
R (Programming Language)
Unix
Next Generation Sequencing
High Throughput Screening
Single Cell Sequencing

Education

Lists including Michael

AP
AO
AS
AN

Based in UK

1884 people

AM
AR
AB
AF

Based in Boston & Cambridge

668 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

S
SANTÉ

2021

  • Senior Associate

    2023

  • Associate

    2021 - 2023

HU
Harvard University

2020 - 2021

  • Visiting Postdoctoral Fellow

    2020 - 2021

    Eggan Lab - Stem Cell & Regenerative Biology

MI
Massachusetts Institute of Technology

2020 - 2021

  • Postdoctoral Fellow

    2020 - 2021

    Manolis Kellis - Computational Biology Group, Broad Institute Affiliate

CS
Cold Spring Harbor Laboratory

2013 - 2019

  • Post-Graduate Researcher

    2019 - 2019

  • Graduate Student

    2013 - 2019

NU
Northwestern University - The Feinberg School of Medicine

2010 - 2013

  • Research Technician II

    2010 - 2013